Statin treatment for COVID-19 to optimise neurological recovery (STRONGER)

Start Date

Date published:

Project locations

STRONGER

BACKGROUND

Statins are one of the most commonly prescribed medications globally to help control the body’s production of cholesterol, but they can also reduce the activity of certain cell proteins involved in the body’s response to infection and inflammation. COVID-19 infection puts patients at high risk of strokes from intense inflammation in the body, and from being critically ill. However, the effects of the virus may linger in the brain to disrupt pathways in more subtle ways that affects thinking, mood and sleep. 

AIM

STRONGER aims to test whether treatment with a popular statin (atorvastatin), widely prescribed to prevent strokes and improve cardiovascular health, has anti-inflammatory effects that can improve memory and thinking after COVID-19 infection.

METHOD

STRONGER is an international randomised clinical trial of atorvastatin versus usual care to assess memory and brain function in 410 adults who have persistent neurological symptoms such as ‘brain fog’, headaches, poor sleep, and disturbed thinking after infection with COVID-19. This is an Australian-Chile collaboration to allow recruitment of patients with a broad range of characteristics and recent and distant COVID-19 infection. The study uses a range of different ways to measure memory and thinking, and advanced brain imaging, to detect early signs of inflammation that may affect brain functions.

IMPACT

If COVID-19 infection results in neurological problems that could be improved using a well-studied, widely available and low-cost treatment, the long-term consequences of the disease on brain function could be avoided.

GET INVOLVED

We are actively recruiting for participants in Australia to join the STRONGER study.

We are offering $100 reimbursement for your time at Baseline and 18-month visits plus reimbursement of any reasonable travel expenses/parking.

If you are interested in learning more about the study and what participation involves, please contact the research team at:

Email: STRONGERstudy@georgeinstitute.org.au

Study website: https://strongerstudy.georgeinstitute.org/

Telephone: +61 2 8052 4842

Leads

Brain health

Professor Craig Anderson

Director, Brain Health Program, The George Institute
Dr Cheryl Carcel, Head, Brain Health Program, The George Institute
Brain health

Dr Cheryl Carcel

Head, Brain Health Program

Podcast

Living through crisis: the COVID-19 situation in India

Episode 3

Duration 30 mins - 45 mins

Icon headphone

Share this Project

  • Icon facebook
  • Icon X
  • Icon Linkedin

Related Content

Brain Health Program

Date published: Node Type: project

New study on brain cooling turns treatment advice on its head

Date published: Node Type: Media release

Can a basic brain scan predict stroke outcomes?

Date published: Node Type: News